ALTO NEUROSCIENCE INC (ANRO) Stock Earnings & Estimates
USA - NYSE:ANRO - US02157Q1094 - Common Stock
11.35 USD
-2.85 (-20.07%)
11.15 USD
-0.2 (-1.76%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 210K | N/A -100.00% | 2.71M | 31.004M 1,044.06% | 167.65M 440.74% | 406.38M 142.40% | 746.39M 83.67% | ||||||
| EBITDA YoY % growth | -11.911M | N/A -142.21% | N/A -29.76% | N/A -81.93% | -80.274M -17.86% | -110.16M -37.23% | -142.8M -29.63% | -201.654M -41.21% | -148.614M 26.30% | -39.372M 73.51% | N/A | N/A | |
| EBIT YoY % growth | -12.056M | N/A -142.14% | -42.2M -29.52% | -74.975M -81.46% | -76.977M -12.20% | -96.35M -25.17% | -111.681M -15.91% | -137.001M -22.67% | -144.308M -5.33% | -38.375M 73.41% | 190.21M 595.66% | 386.62M 103.26% | |
| Operating Margin | -5,740.95% | N/A | N/A | N/A | N/A | N/A | N/A | -5,055.38% | -465.45% | -22.89% | 46.81% | 51.80% | |
| EPS YoY % growth | N/A | N/A | -4.78 | -2.64 46.85% | -2.51 1.03% | -2.45 2.35% | -2.48 -1.09% | -3.65 -47.15% | -1.92 47.49% | 3.97 306.91% | N/A | N/A |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.63 -11.81% | -0.67 -18.94% | -0.69 -5.95% | -0.64 -22.60% | -0.72 -14.95% | -0.53 20.37% | -0.54 21.50% | -0.58 8.80% | -0.65 9.31% |
| Revenue Q2Q % growth | N/A | N/A | N/A | N/A | |||||
| EBITDA Q2Q % growth | -22.542M -36.66% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -20.997M -23.53% | -22.888M -46.01% | -23.78M -27.29% | -25.457M -25.32% | -26.463M -26.03% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | -0.52 16.13% | -0.68 | 0.16 | 23.65% |
| Q2 2025 Q2Q % growth | -0.65 -8.33% | -0.63 | -0.02 | -3.96% |
| Q1 2025 Q2Q % growth | -0.56 26.32% | -0.62 | 0.06 | 9.70% |
| Q4 2024 Q2Q % growth | -0.56 92.79% | -0.66 | 0.10 | 15.54% |
| Q3 2024 Q2Q % growth | -0.62 | -0.67 | 0.05 | 6.96% |
| Q2 2024 Q2Q % growth | -0.60 | -0.68 | 0.08 | 12.20% |
| Q1 2024 Q2Q % growth | -0.76 | -0.47 | -0.29 | -61.28% |
| Q4 2023 Q2Q % growth | -7.77 | -1.70 | -6.07 | -356.11% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 5.42% | -1.42% | 2.89% | 0.14% |
| Revenue | N/A | N/A | N/A | N/A |